Compound K is able to ameliorate the impaired cognitive function and hippocampal neurogenesis following chemotherapy treatment

Biochemical and Biophysical Research Communications

Volumn 436, Issue 1, 2013, Pages 104-109

  Hou, Jin gang ^a   Xue, Jian jie ^a   Lee, Mi ra ^a   Sun, Meng qi ^b   Zhao, Xing hua ^c   Zheng, Yi nan ^d   Sung, Chang keun ^a  

^a Chungnam National University   (South Korea)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c Cangzhou Medical College   (China)

^d JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Amelioration; Chemotherapy agent; Compound K; Neurogenesis

Indexed keywords

COMPOUND K; CYCLOPHOSPHAMIDE; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STEM CELL; WEIGHT CHANGE;

ANIMALS; ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; GINSENOSIDES; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED ICR; NEURONS; STEM CELLS; TIME FACTORS;

MUS;

EID: 84879148677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.087     Document Type: Article

References (25)

1. Matalon S.T., Ornoy A., Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (Cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reprod. Toxicol. 2004, 18:219-230.
2. Janelsins M.C., Roscoe J.A., Berg M.J., Thompson B.D., Gallagher M.J., Morrow G.R., Heckler C.E., Jean-Pierre P., Opanashuk L.A., Gross R.A. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest. 2010, 28:544-553.
3. Altman J., Bayer S.A. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J. Comp. Neurol. 1990, 301:365-381.
4. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 1999, 2:260-265.
5. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiatry 1999, 46:1472-1479.
6. Gross C.G. Neurogenesis in the adult brain: death of a dogma. Nat. Rev. Neurosci. 2000, 1:67-73.
7. Reiriz A.B., Reolon G.K., Preissler T., Rosado J.O., Henriques J.A., Roesler R., Schwartsmann G. Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin. Cancer Res. 2006, 12:5000. (author reply 5000-5001.).
8. Yang M., Kim J.S., Song M.S., Kim S.H., Kang S.S., Bae C.S., Kim J.C., Wang H., Shin T., Moon C. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol. Learn. Mem. 2010, 93:487-494.
9. Konat G.W., Kraszpulski M., James I., Zhang H.T., Abraham J. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab. Brain Dis. 2008, 23:325-333.
10. MacLeod J.E., DeLeo J.A., Hickey W.F., Ahles T.A., Saykin A.J., Bucci D.J. Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav. Brain Res. 2007, 181:168-172.
11. Christie L.A., Acharya M.M., Parihar V.K., Nguyen A., Martirosian V., Limoli C.L. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin. Cancer Res. 2012, 18:1954-1965.
12. Briones T.L., Woods J. Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neuroscience 2011, 12.
13. Lee G.D., Longo D.L., Wang Y., Rifkind J.M., Abdul-Raman L., Mamczarz J.A., Duffy K.B., Spangler E.L., Taub D.D., Mattson M.P., Ingram D.K. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. Clin. Cancer Res. 2006, 12:198-205.
14. Zhang G., Liu A., Zhou Y., San X., Jin T., Jin Y. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J. Ethnopharmacol. 2008, 115:441-448.
15. Yang J.H., Han S.J., Ryu J.H., Jang I.S., Kim D.H. Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice. Biol. Pharm. Bull. 2009, 32:1710-1715.
16. Kim D.Y., Yuan H.D., Chung I.K., Chung S.H. Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via ampk activation in human hepatoma cells. J. Agric. Food Chem. 2009, 57:1532-1537.
17. Chae S., Kang K.A., Chang W.Y., Kim M.J., Lee S.J., Lee Y.S., Kim H.S., Kim D.H., Hyun J.W. Effect of Compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in Vitro and in Vivo. J. Agric. Food Chem. 2009, 57:5777-5782.
18. Zhang Z., Du G.J., Wang C.Z., Wen X.D., Calway T., Li Z., He T.C., Du W., Bissonnette M., Musch M.W., Chang E.B., Yuan C.S. Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. Int. J. Mol. Sci. 2013, 14:2980-2995.
19. Kempermann G., Gast D., Kronenberg G., Yamaguchi M., Gage F.H. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 2003, 130:391-399.
20. Bao H., Zhang J., Yeo S., Myung C.-S., Kim H., Kim J., Park J., Cho J., Kang J. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch. Pharmacal Res. 2005, 28:335-342.
21. Barton D., Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clin. Breast Cancer 2002, 3:S121-S127.
22. Kang K., Kim Y., Kim S., Chae S., Koh Y., Kim H., Choo M., Kim D., Hyun J. G1 phase arrest of the cell cycle by a ginseng metabolite, compound K, in U937 human monocytic leukamia cells. Arch. Pharmacal Res. 2005, 28:685-690.
23. Cai B.-X., Luo D., Lin X.-F., Gao J. Compound K suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair in human keratinocytes. Arch. Pharmacal Res. 2008, 31:1483-1488.
24. Park J.-S., Shin J.A., Jung J.-S., Hyun J.-W., Van Le T.K., Kim D.-H., Park E.-M., Kim H.-S. Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J. Pharmacol. Exp. Ther. 2012, 341:59-67.
25. Joh E.-H., Lee I.-A., Jung I.-H., Kim D.-H. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem. Pharmacol. 2011, 82:278-286.